Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111681234 | 11168123 | 4 | F | 201411 | 20160630 | 20150605 | 20160711 | EXP | US-JNJFOC-20150516966 | JANSSEN | 65.28 | YR | A | F | Y | 73.48000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111681234 | 11168123 | 1 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | Y | U | 1405368P1;1405368P1;1405368P1 | 0 | MATRIX PATCH | |||||||
| 111681234 | 11168123 | 2 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | Y | U | 1405368P1;1405368P1;1405368P1 | 0 | MATRIX PATCH | |||||||
| 111681234 | 11168123 | 3 | SS | DURAGESIC | FENTANYL | 1 | Transdermal | Y | U | 1405368P1;1405368P1;1405368P1 | 0 | MATRIX PATCH | |||||||
| 111681234 | 11168123 | 4 | PS | DURAGESIC | FENTANYL | 1 | Transdermal | Y | U | 1405368P1;1405368P1;1405368P1 | 19813 | MATRIX PATCH | |||||||
| 111681234 | 11168123 | 5 | C | CALCIUM AND VITAMIN D | CALCIUMVITAMIN D | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111681234 | 11168123 | 1 | Pain |
| 111681234 | 11168123 | 2 | Pain |
| 111681234 | 11168123 | 3 | Pain |
| 111681234 | 11168123 | 4 | Pain |
| 111681234 | 11168123 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111681234 | 11168123 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111681234 | 11168123 | Adverse drug reaction | |
| 111681234 | 11168123 | Cataract | |
| 111681234 | 11168123 | Nasal congestion | |
| 111681234 | 11168123 | Pain | |
| 111681234 | 11168123 | Product packaging issue | |
| 111681234 | 11168123 | Sneezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111681234 | 11168123 | 2 | 20100815 | 0 | ||
| 111681234 | 11168123 | 3 | 2014 | 0 | ||
| 111681234 | 11168123 | 4 | 2015 | 0 |